Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.3.1.900
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Revenues        
Product $ 3,473 $ 2,474 $ 9,793 $ 6,671
Product licensing fees and royalties 120 555 906 2,601
Service 227 189 855 602
Total revenues 3,820 3,218 11,554 9,874
Cost of revenues        
Product 2,123 1,417 5,356 4,107
Service 177 145 715 473
Total cost of revenues 2,300 1,562 6,071 4,580
Gross profit 1,520 1,656 5,483 5,294
Operating expenses        
Research and development 486 367 1,365 1,159
Selling, general and administrative 4,158 3,238 11,411 9,142
Total operating expenses 4,644 3,605 12,776 10,301
Loss from operations (3,124) (1,949) (7,293) (5,007)
Interest expense 0 0 (1) (4)
Interest income 0 1 1 1
Gain due to change in fair value of derivative liabilities 4 679 10 2,998
Loss on impairment of investment held at cost 0 (4,650) 0 (4,650)
Other (expense) income, net (29) 5 31 (40)
Net loss $ (3,149) $ (5,914) $ (7,252) $ (6,702)
Net loss per common share: basic and diluted $ (.19) $ (.69) $ (.45) $ (.79)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted 1,646,700 8,600,000 15,974,000 8,494,000
Other comprehensive loss        
Net loss $ (3,149) $ (5,914) $ (7,252) $ (6,702)
Foreign currency translation adjustments (68) (202) (392) (304)
Comprehensive loss $ (3,217) $ (6,116) $ (7,644) $ (7,006)